Skip to main content
. 2009 May 22;3(3):468–479. doi: 10.1007/s12072-009-9134-1

Fig. 5.

Fig. 5

The cost of treating patients infected with HCV genotype 2 or low viral load genotype 1 and RVR for 48, 28, or 24 weeks followed by 48 weeks of re-treatment of 40% of patients who relapse after the initial treatment